Indoco Remedies clinical research organisation AnaCipher gets UK MHRA accreditation

Written by Ruchika Sharma Published On 2021-08-28T11:30:42+05:30 | Updated On 28 Aug 2021 6:52 PM IST

Indoco Remedies clinical research organisation AnaCipher gets UK MHRA accreditation

Mumbai: Indoco Remedies Ltd. has recently announced the receipt of GCP & GLP accreditation from the UK-MHRA (Medicines and Healthcare Products Regulatory Agency) for its Clinical Research Organisation - AnaCipher, located at Hyderabad for the virtual inspection carried out from 4th – 7th May and 10th - 11th May, 2021.

The inspection covered all the phases of Bioequivalence studies and was conducted successfully.

"This is an exciting step in our journey of excellence and a validation of our adherence to delivering quality services to our customers worldwide.", stated Ms. Aditi Kare Panandikar, Managing Director, Indoco Remedies Limited.

AnaCipher CRO, based in Hyderabad, is a USFDA inspected clinical research facility and is spread over 30,000 sq. ft area with 98 beds and staffed by experienced professionals providing clinical trial solutions and conducts Bioequivalence and Bioavailability (BA/BE) studies at its facility. The CRO has successfully completed more than 500 studies in multiple therapeutic areas such as, cardiovascular, diabetes, oncology, anti-retrovirals and antacids.

Indoco Remedies Ltd., headquartered in Mumbai, is a fully integrated, research-oriented pharma company with presence in 55 countries

Indoco has 9 domestic marketing divisions with a strong brand portfolio in various therapeutic segments including Gastro-intestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritional, Cardiovascular, Anti-Diabetics, Pain Management, etc. Top Indoco brands include Cyclopam, Febrex Plus, SensodentK, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM, Methycal, etc.

Read also: Indoco Remedies bags tenders worth Rs 140 crore for Allopurinol Tablets in Germany

indoco remediesindoco remedies newsanacipherUK MHRA

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751